Vitiligo represents a significant public heath challenge. GLOVA is an extensive initiative aiming to promote ongoing progress in understanding vitiligo and revealing its impact on individuals and society as a whole.

​

This project is a partnership between three prominent global organisations in the field of dermatology:

 

The Vitiligo International Society (VIS), the International League of Dermatological Societies (ILDS), and the Vitiligo Patient  Organisation (VIPOC).​​

​

Epidemiological studies can be used to:

​• Understand the causes and patterns of vitiligo.

• Describe quality of life, identify trends in health care

• Prioritise research needs.

• Quantify the risk of major comorbidities including ear and eye abnormalities.

​​

They can also help investigating the natural history of vitiligo, and identify environmental factors influencing disease onset or flare and its comorbidities. ​Together, the information can be positioned to quantify the financial burden to society and ultimately to shape policy decisions.